KILITCHNSEKilitch Drugs (India) Limited· PharmaceuticalsLowNeutral
Announced Fri, 14 Nov · 20:47 IST

we are submitting the monitoring agency report for the quarter ended 30th September, 2025

KILITCH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kilitch Drugs (India) Limited has submitted the Monitoring Agency Report for the quarter ended 30th September 2025 to the stock exchanges. A Monitoring Agency Report is a regulatory filing required when a company has raised funds through preferential issues, qualified institutional placements, or other non-conventional routes, and a SEBI-registered monitoring agency tracks whether the company is using the raised money for the stated purpose. This is a routine compliance disclosure and indicates the company has prior fundraising activity that requires such monitoring. The actual report detailing fund utilization and any deviations would be available as an attachment to this filing.

Likely market impact

Neutral impact on shareholders in the short term. Investors should review the attached report to check whether the company is utilizing raised funds as originally disclosed, as any significant deviation could be a red flag for corporate governance.